pre-miRNA Information
pre-miRNA hsa-mir-4734   
Genomic Coordinates chr17: 38702262 - 38702331
Description Homo sapiens miR-4734 stem-loop
Comment None
RNA Secondary Structure

Mature miRNA Information
Mature miRNA hsa-miR-4734
Sequence 41| GCUGCGGGCUGCGGUCAGGGCG |62
Evidence Experimental
Experiments Illumina
SNPs in miRNA
Mutant ID Mutant Position Mutant Source
rs1226851679 2 dbSNP
rs1021398156 12 dbSNP
rs1011056563 13 dbSNP
rs1298210202 21 dbSNP
Putative Targets

miRNA Expression profile
Human miRNA Tissue Atlas
Circulating MicroRNA Expression Profiling
Gene Information
Gene Symbol ZBTB3   
Synonyms -
Description zinc finger and BTB domain containing 3
Transcript NM_024784   
Expression
Putative miRNA Targets on ZBTB3
3'UTR of ZBTB3
(miRNA target sites are highlighted)
>ZBTB3|NM_024784|3'UTR
   1 GGGAGCATGAGCTGATGCTAGGCTGCTCTTACCATCCTTAGATGGCAGCTCAGAAGGTTGGTGGCACCTTATCACCCCTG
  81 CTGGGTGACAAGAATAAAGGCTCTGCCCAGGCTGAAAGTTCCTACCCTTTTTTTTTTTTAATCTTTTATTTTTTTGAGAC
 161 AGAGTCTCACTCTGTCACCCAGACTGGAGTGCAGTGGCGCGATCTCGGCTCACTGCAAGCTCAGCCTCCCCGATTCACGC
 241 CATTCTCCTGCCTCAGCCTCCCGAGTAGCTGGGACTACAGGCGCCTATCACCATGCCTGGCTAATTTTTTTTGATTTTTA
 321 GTAGAGACAGGGTTTCACCGTGTTAGCCAGGATGGTCTCGATCTTCTGACAGATCTGACCTCGTGATCCGCCCATCTCCA
 401 CCTCCCGCAGTGCTGGGATTACAGGCATGAGCCACCGCGCCCAGCTGCCTTTTTTTTTTTGAGTCTTGCTCTGTCACTGA
 481 GGCTGGAGTGCAGTGGCGCAATTTCAGCTCACTGCAACCTCTGCCTCCCAGGTTCAAGCGATTCCTTTTTTTTTTTTTTT
 561 TTTTGAGACAGAGTCTCACTCTGTCCCCCAGGCTGGAGTGCAGTGGCGCGATCTTGGCCCACCACGCCCGCCTAATTTTT
 641 TGTATTTTTTAGTAGAGACGGGGTTTCACCGTGTTAGTCAGGATGGTCTCGATCTCCTGACCTCGTGATCCACCCGCCTC
 721 AGCCTCCCAAAGTGCTGGGATTACAGGCTTGAGCCACCGTGCCTGGCCTCAAGCGATTCTCTTAACTCAGCCTCTTGAGT
 801 AGCTGGGATTACAGGAACGCGCCACCACGCCCAGCTAATTCCTGTATTTTTAGTAGAGACAGGGTTTCACCATGTTGGCC
 881 AGGCTGGTCTCAAATTCCTGACCCCAGGTGATCTGCCCACCTTGGCCTTAAAAAGTGCTGGGATTAAAGGCGTGAGCCAC
 961 CATGCCCAGCCTCCTACCCTTTTCTTTGCCCAGCCAGATAAGCAGGACTTTATGGGGCAAAGCCTATGTCAGCTCTCTCC
1041 AAGGGCACTGGGAATTTTCCTGAGGTGTAATCGCTTCTCACTGTATGTTCTGGAACATAAAGCTAGCAATGAAGGTATTT
1121 CTTTGAAAAAAAAAAAAAAAAAA
Target sites Provided by authors   Predicted by miRanda    DRVs    SNPs    DRVs & SNPs
miRNA-target interactions
(Predicted by miRanda)
ID Duplex structure Position Score MFE
1
miRNA  3' gcGGGACUGGCGUCGGGCGUCg 5'
            || |  || |  ||||||| 
Target 5' gcCCATCTCCACCTCCCGCAGt 3'
390 - 411 152.00 -23.50
2
miRNA  3' gcgGGACUGGCGUCGGGCGUCg 5'
             :|| ||: :: ||| ||| 
Target 5' gagTCTCACTCTGTCCCCCAGg 3'
571 - 592 123.00 -12.40
3
miRNA  3' gcGGGACUGG--CGU-CGGGCGucg 5'
            :|:||:||   || ||||||   
Target 5' gaTCTTGGCCCACCACGCCCGCcta 3'
610 - 634 122.00 -21.62
Experimental Support 1 for Functional miRNA-Target Interaction
miRNA:Target ----
Validation Method
     
Conditions HEK293S
Location of target site 3'UTR
Tools used in this research TargetScan , miRTarCLIP , Piranha
Original Description (Extracted from the article) ... HITS-CLIP data was present in GSM1084068. RNA binding protein: AGO2. Condition:CLIP_noemetine_SigmaAb HITS-CLIP data was present in GSM1084072. RNA binding protein: AGO2. Condition:CLIP_nohippuristanol_rep1_AbnovaAb HITS-CLIP data was present in GSM1084077. RNA binding protein: AGO2. Condition:CLIP_hippuristanol_rep1_SigmaAb ...

- Karginov FV; Hannon GJ, 2013, Genes & development.

Article - Karginov FV; Hannon GJ
- Genes & development, 2013
When adapting to environmental stress, cells attenuate and reprogram their translational output. In part, these altered translation profiles are established through changes in the interactions between RNA-binding proteins and mRNAs. The Argonaute 2 (Ago2)/microRNA (miRNA) machinery has been shown to participate in stress-induced translational up-regulation of a particular mRNA, CAT-1; however, a detailed, transcriptome-wide understanding of the involvement of Ago2 in the process has been lacking. Here, we profiled the overall changes in Ago2-mRNA interactions upon arsenite stress by cross-linking immunoprecipitation (CLIP) followed by high-throughput sequencing (CLIP-seq). Ago2 displayed a significant remodeling of its transcript occupancy, with the majority of 3' untranslated region (UTR) and coding sequence (CDS) sites exhibiting stronger interaction. Interestingly, target sites that were destined for release from Ago2 upon stress were depleted in miRNA complementarity signatures, suggesting an alternative mode of interaction. To compare the changes in Ago2-binding patterns across transcripts with changes in their translational states, we measured mRNA profiles on ribosome/polysome gradients by RNA sequencing (RNA-seq). Increased Ago2 occupancy correlated with stronger repression of translation for those mRNAs, as evidenced by a shift toward lighter gradient fractions upon stress, while release of Ago2 was associated with the limited number of transcripts that remained translated. Taken together, these data point to a role for Ago2 and the mammalian miRNAs in mediating the translational component of the stress response.
LinkOut: [PMID: 23824327]
CLIP-seq Support 1 for dataset GSM4903836
Method / RBP HITS-CLIP / AGO
Cell line / Condition Dermal fibroblasts / 124_TD_21_a
Location of target site NM_024784 | 3UTR | GUGCUGGGAUUACAG
Tools used in this analysis TargetScan, miRTarCLIP, and Piranha
Accession Series GSE161239
CLIP-seq Viewer Link
CLIP-seq Support 2 for dataset GSM1084068
Method / RBP HITS-CLIP / AGO2
Cell line / Condition HEK293S / CLIP_noemetine_SigmaAb
Location of target site ENST00000394807.3 | 3UTR | GCAGUGCUGGGAUUACAGGC
Tools used in this analysis TargetScan, miRTarCLIP, and Piranha
Article / Accession Series PMID: 23824327 / GSE44404
CLIP-seq Viewer Link
CLIP-seq Support 3 for dataset GSM1084072
Method / RBP HITS-CLIP / AGO2
Cell line / Condition HEK293S / CLIP_nohippuristanol_rep1_AbnovaAb
Location of target site ENST00000394807.3 | 3UTR | GCAGUGCUGGGAUUACAGGCAUGAGC
Tools used in this analysis TargetScan, miRTarCLIP, and Piranha
Article / Accession Series PMID: 23824327 / GSE44404
CLIP-seq Viewer Link
CLIP-seq Support 4 for dataset GSM1084077
Method / RBP HITS-CLIP / AGO2
Cell line / Condition HEK293S / CLIP_hippuristanol_rep1_SigmaAb
Location of target site ENST00000394807.3 | 3UTR | GCAGUGCUGGGAUUACAGGCAUGAGC
Tools used in this analysis TargetScan, miRTarCLIP, and Piranha
Article / Accession Series PMID: 23824327 / GSE44404
CLIP-seq Viewer Link
MiRNA-Target Expression Profile
Dataset Pearson Correlation P-value for Pearson Correlation Spearman Correlation P-value for Spearman Correlation Samples Chart
MiRNA-Target Expression Profile (TCGA)
Tumor Pearson Correlation P-value for Pearson Correlation Spearman Correlation P-value for Spearman Correlation Samples Chart
15 hsa-miR-4734 Target Genes:
Functional analysis:
ID Target Description Validation methods
Strong evidence Less strong evidence
MIRT460716 FN3KRP fructosamine 3 kinase related protein 2 2
MIRT467603 SLC7A5 solute carrier family 7 member 5 2 2
MIRT477489 ELL2 elongation factor for RNA polymerase II 2 2 2
MIRT481373 ATG9A autophagy related 9A 2 2
MIRT486420 RXRA retinoid X receptor alpha 2 2
MIRT491673 AQP2 aquaporin 2 2 2
MIRT504626 SCIN scinderin 2 6
MIRT516768 FAM212B family with sequence similarity 212 member B 2 4
MIRT570599 NFIX nuclear factor I X 2 2
MIRT608761 CACNA1A calcium voltage-gated channel subunit alpha1 A 2 2
MIRT615150 URGCP-MRPS24 URGCP-MRPS24 readthrough 2 2
MIRT617122 ZNF556 zinc finger protein 556 2 2
MIRT628615 ZBTB3 zinc finger and BTB domain containing 3 2 2
MIRT702726 INSIG1 insulin induced gene 1 2 2
MIRT712897 TGFA transforming growth factor alpha 2 2
miRNA-Drug Associations
miRNA Small Melocule FDA CID Detection Method Condition PMID Year Expression Pattern of miRNA
miR-4 Dexamethasone approved 5743 Microarray primary rat thymocytes 20847043 2010 up-regulated
miRNA-Drug Resistance Associations
miRNA Drug Name CID NSC FDA Effect/Pattern Detection Method Level Phenotype Condition
hsa-miR-4734 Dabrafenib 44462760 NSC764134 approved resistant High Melanoma cell line (A375, IGR37, 501Mel)
hsa-miR-4734 Vemurafenib 42611257 NSC761431 approved resistant High Melanoma cell line (A375, IGR37, 501Mel)
hsa-miR-4734 Doxorubicin 31703 NSC123127 approved sensitive High Breast Cancer cell line (MCF-7)
hsa-miR-4734 Curcumin 969516 NSC32982 approved sensitive High Breast Cancer cell line (MCF-7)
hsa-miR-4734 Paclitaxel 36314 NSC125973 approved resistant High Non-Small Cell Lung Cancer cell line (A549)
hsa-miR-4734 Tamoxifen 2733525 NSC180973 approved resistant High Breast Cancer cell line (MCF-7)
hsa-miR-4734 Fulvestrant 17756771 NSC719276 approved sensitive High Breast Cancer cell line (MCF-7)
hsa-miR-4734 Gefitinib 123631 NSC715055 approved sensitive High Non-Small Cell Lung Cancer cell line (PC-9)
hsa-miR-4734 Gemcitabine 60750 NSC613327 approved sensitive High Pancreatic Cancer cell line (AsPC-1)
hsa-miR-4734 Oxaliplatin 6857599 NSC266046 approved resistant Low Colorectal Cancer cell line (SW480, HCT-116)
hsa-mir-4734 Dabrafenib 44462760 NSC764134 approved resistant cell line (A375)
hsa-mir-4734 Doxorubicin 31703 NSC123127 approved resistant cell line (BAS)
hsa-mir-4734 Cisplatin 5460033 NSC119875 approved resistant cell line (A2780)
hsa-mir-4734 Cisplatin 5460033 NSC119875 approved resistant cell line (BxPC3)
hsa-miR-4734 Cisplatin 5460033 NSC119875 approved sensitive cell line
hsa-miR-4734 Cisplatin 5460033 NSC119875 approved resistant cell line (A549)
hsa-miR-4734 Gefitinib 123631 NSC715055 approved resistant cell line (HCC827)
hsa-miR-4734 Paclitaxel 36314 NSC125973 approved sensitive cell line (BAS)
hsa-miR-4734 Doxorubicin 31703 NSC123127 approved resistant cell line (BAS)
hsa-miR-4734 Doxorubicin 31703 NSC123127 approved resistant cell line (HS578T)
hsa-miR-4734 Cisplatin 5460033 NSC119875 approved resistant cell line (CIS)
hsa-miR-4734 Gemcitabine 60750 NSC613327 approved sensitive cell line (PANC-1) (100 ng/ml)

Error report submission